Abstract
Males are predominantly affected by autism spectrum disorders (ASD) with a prevalence ratio of 5:1. However, the underlying pathological mechanisms governing the male preponderance of ASD remain unclear. Recent studies suggested that epigenetic aberrations may cause synaptic dysfunctions, which might be related to the pathophysiology of ASD. In this study, we used rat offspring prenatally exposed to valproic acid (VPA) as an animal model of ASD. We found male-selective abnormalities in the kinetic profile of the excitatory glutamatergic synaptic protein expressions linked to N-methyl-d-aspartate receptor (NMDAR), alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) and metabotropic glutamate receptor 5 (mGluR5) pathways in the prefrontal cortex of the VPA-exposed offspring at postnatal weeks 1, 2, and 4. Furthermore, VPA exposure showed a male-specific attenuation of the methyl-CpG-binding protein 2 (MeCP2) expressions both in the prefrontal cortex of offspring and in the gender-isolated neural progenitor cells (NPCs). In the gender-isolated NPCs culture, higher concentration of VPA induced an increased glutamatergic synaptic development along with decreased MeCP2 expression in both genders suggesting the role of MeCP2 in the modulation of synaptic development. In the small interfering RNA (siRNA) knock-down study, 50 pmol of Mecp2 siRNA inhibited the MeCP2 expression in male- but not in female-derived NPCs with concomitant induction of postsynaptic proteins such as PSD95. Taken together, we suggest that the male-inclined reduction of MeCP2 expression is involved in the abnormal development of glutamatergic synapse and male preponderance in the VPA animal models of ASD.
Similar content being viewed by others
References
Zahn-Waxler C, Shirtcliff EA, Marceau K (2008) Disorders of childhood and adolescence: gender and psychopathology. Annu Rev Clin Psychol 4:275–303. doi:10.1146/annurev.clinpsy.3.022806.091358
Kim YS, Leventhal BL, Koh YJ, Fombonne E, Laska E, Lim EC, Cheon KA, Kim SJ, Kim YK, Lee H, Song DH, Grinker RR (2011) Prevalence of autism spectrum disorders in a total population sample. Am J Psychiatr 168(9):904–912. doi:10.1176/appi.ajp.2011.10101532
Gillberg C, Cederlund M, Lamberg K, Zeijlon L (2006) Brief report: “the autism epidemic”. The registered prevalence of autism in a Swedish urban area. J Autism Dev Disord 36(3):429–435. doi:10.1007/s10803-006-0081-6
Baron-Cohen S (2002) The extreme male brain theory of autism. Trends Cogn Sci 6(6):248–254
Baron-Cohen S (2010) Empathizing, systemizing, and the extreme male brain theory of autism. Prog Brain Res 186:167–175. doi:10.1016/B978-0-444-53630-3.00011-7
Baron-Cohen S, Lombardo MV, Auyeung B, Ashwin E, Chakrabarti B, Knickmeyer R (2011) Why are autism spectrum conditions more prevalent in males? PLoS Biol 9(6):e1001081. doi:10.1371/journal.pbio.1001081
Zhang FF, Cardarelli R, Carroll J, Fulda KG, Kaur M, Gonzalez K, Vishwanatha JK, Santella RM, Morabia A (2011) Significant differences in global genomic DNA methylation by gender and race/ethnicity in peripheral blood. Epigenetics Off J DNA Methylation Soc 6(5):623–629
Boks MP, Derks EM, Weisenberger DJ, Strengman E, Janson E, Sommer IE, Kahn RS, Ophoff RA (2009) The relationship of DNA methylation with age, gender and genotype in twins and healthy controls. PLoS One 4(8):e6767. doi:10.1371/journal.pone.0006767
Champagne FA, Weaver IC, Diorio J, Dymov S, Szyf M, Meaney MJ (2006) Maternal care associated with methylation of the estrogen receptor-alpha1b promoter and estrogen receptor-alpha expression in the medial preoptic area of female offspring. Endocrinology 147(6):2909–2915. doi:10.1210/en.2005-1119
Nishijo M, Satarug S, Honda R, Tsuritani I, Aoshima K (2004) The gender differences in health effects of environmental cadmium exposure and potential mechanisms. Mol Cell Biochem 255(1–2):87–92
Kundakovic M, Gudsnuk K, Franks B, Madrid J, Miller RL, Perera FP, Champagne FA (2013) Sex-specific epigenetic disruption and behavioral changes following low-dose in utero bisphenol A exposure. Proc Natl Acad Sci U S A 110(24):9956–9961. doi:10.1073/pnas.1214056110
Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY (1999) Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 23(2):185–188. doi:10.1038/13810
American Psychiatric Association A (2013) Diagnostic and statistical manual of mental disorders: (5th ed.). American Psychiatric Publishing
Rett A (1966) On a unusual brain atrophy syndrome in hyperammonemia in childhood. Wien Med Wochenschr 116(37):723–726
Hagberg B, Aicardi J, Dias K, Ramos O (1983) A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett’s syndrome: report of 35 cases. Ann Neurol 14(4):471–479. doi:10.1002/ana.410140412
Laurvick CL, de Klerk N, Bower C, Christodoulou J, Ravine D, Ellaway C, Williamson S, Leonard H (2006) Rett syndrome in Australia: a review of the epidemiology. J Pediatr 148(3):347–352. doi:10.1016/j.jpeds.2005.10.037
Nagarajan RP, Hogart AR, Gwye Y, Martin MR, LaSalle JM (2006) Reduced MeCP2 expression is frequent in autism frontal cortex and correlates with aberrant MECP2 promoter methylation. Epigenetics Off J DNA Methylation Soc 1(4):e1–e11
Zhang A, Shen CH, Ma SY, Ke Y, El Idrissi A (2009) Altered expression of autism-associated genes in the brain of Fragile X mouse model. Biochem Biophys Res Commun 379(4):920–923. doi:10.1016/j.bbrc.2008.12.172
Blue ME, Naidu S, Johnston MV (1999) Altered development of glutamate and GABA receptors in the basal ganglia of girls with Rett syndrome. Exp Neurol 156(2):345–352. doi:10.1006/exnr.1999.7030
Blue ME, Naidu S, Johnston MV (1999) Development of amino acid receptors in frontal cortex from girls with Rett syndrome. Ann Neurol 45(4):541–545
Blue ME, Kaufmann WE, Bressler J, Eyring C, O'Driscoll C, Naidu S, Johnston MV (2011) Temporal and regional alterations in NMDA receptor expression in Mecp2-null mice. Anat Rec (Hoboken) 294(10):1624–1634. doi:10.1002/ar.21380
Kim KC, Lee DK, Go HS, Kim P, Choi CS, Kim JW, Jeon SJ, Song MR, Shin CY (2014) Pax6-dependent cortical glutamatergic neuronal differentiation regulates autism-like behavior in prenatally valproic acid-exposed rat offspring. Mol Neurobiol 49(1):512–528. doi:10.1007/s12035-013-8535-2
LeBlanc JJ, Fagiolini M (2011) Autism: a “critical period” disorder? Neural Plast 2011:921680. doi:10.1155/2011/921680
Jian L, Nagarajan L, de Klerk N, Ravine D, Bower C, Anderson A, Williamson S, Christodoulou J, Leonard H (2006) Predictors of seizure onset in Rett syndrome. J Pediatr 149(4):542–547. doi:10.1016/j.jpeds.2006.06.015
Moser SJ, Weber P, Lutschg J (2007) Rett syndrome: clinical and electrophysiologic aspects. Pediatr Neurol 36(2):95–100. doi:10.1016/j.pediatrneurol.2006.10.003
Chao HT, Zoghbi HY, Rosenmund C (2007) MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number. Neuron 56(1):58–65. doi:10.1016/j.neuron.2007.08.018
Chao HT, Chen H, Samaco RC, Xue M, Chahrour M, Yoo J, Neul JL, Gong S, Lu HC, Heintz N, Ekker M, Rubenstein JL, Noebels JL, Rosenmund C, Zoghbi HY (2010) Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes. Nature 468(7321):263–269. doi:10.1038/nature09582
D'Cruz JA, Wu C, Zahid T, El-Hayek Y, Zhang L, Eubanks JH (2010) Alterations of cortical and hippocampal EEG activity in MeCP2-deficient mice. Neurobiol Dis 38(1):8–16. doi:10.1016/j.nbd.2009.12.018
Calfa G, Hablitz JJ, Pozzo-Miller L (2011) Network hyperexcitability in hippocampal slices from Mecp2 mutant mice revealed by voltage-sensitive dye imaging. J Neurophysiol 105(4):1768–1784. doi:10.1152/jn.00800.2010
Kim KC, Kim P, Go HS, Choi CS, Park JH, Kim HJ, Jeon SJ, Dela Pena IC, Han SH, Cheong JH, Ryu JH, Shin CY (2013) Male-specific alteration in excitatory postsynaptic development and social interaction in prenatal valproic acid exposure model of autism spectrum disorder. J Neurochem. doi:10.1111/jnc.12147
Courchesne E, Mouton PR, Calhoun ME, Semendeferi K, Ahrens-Barbeau C, Hallet MJ, Barnes CC, Pierce K (2011) Neuron number and size in prefrontal cortex of children with autism. JAMA 306(18):2001–2010. doi:10.1001/jama.2011.1638
Zikopoulos B, Barbas H (2013) Altered neural connectivity in excitatory and inhibitory cortical circuits in autism. Front Hum Neurosci 7:609. doi:10.3389/fnhum.2013.00609
Courchesne E, Pierce K (2005) Why the frontal cortex in autism might be talking only to itself: local over-connectivity but long-distance disconnection. Curr Opin Neurobiol 15(2):225–230. doi:10.1016/j.conb.2005.03.001
Rinaldi T, Perrodin C, Markram H (2008) Hyper-connectivity and hyper-plasticity in the medial prefrontal cortex in the valproic acid animal model of autism. Front Neural Circ 2:4. doi:10.3389/neuro.04.004.2008
Go HS, Kim KC, Choi CS, Jeon SJ, Kwon KJ, Han SH, Lee J, Cheong JH, Ryu JH, Kim CH, Ko KH, Shin CY (2012) Prenatal exposure to valproic acid increases the neural progenitor cell pool and induces macrocephaly in rat brain via a mechanism involving the GSK-3beta/beta-catenin pathway. Neuropharmacology 63(6):1028–1041. doi:10.1016/j.neuropharm.2012.07.028
Yang Y, Raine A (2009) Prefrontal structural and functional brain imaging findings in antisocial, violent, and psychopathic individuals: a meta-analysis. Psychiatry Res 174(2):81–88. doi:10.1016/j.pscychresns.2009.03.012
Benoit BO, Savarese T, Joly M, Engstrom CM, Pang L, Reilly J, Recht LD, Ross AH, Quesenberry PJ (2001) Neurotrophin channeling of neural progenitor cell differentiation. J Neurobiol 46(4):265–280. doi:10.1002/1097-4695(200103)46:4<265::AID-NEU1007>3.0.CO;2-B
Conti L, Pollard SM, Gorba T, Reitano E, Toselli M, Biella G, Sun Y, Sanzone S, Ying QL, Cattaneo E, Smith A (2005) Niche-independent symmetrical self-renewal of a mammalian tissue stem cell. PLoS Biol 3(9):e283. doi:10.1371/journal.pbio.0030283
Go HS, Shin CY, Lee SH, Jeon SJ, Kim KC, Choi CS, Ko KH (2009) Increased proliferation and gliogenesis of cultured rat neural progenitor cells by lipopolysaccharide-stimulated astrocytes. Neuroimmunomodulation 16(6):365–376. doi:10.1159/000228911
Levine E, Cupp AS, Skinner MK (2000) Role of neurotropins in rat embryonic testis morphogenesis (cord formation). Biol Reprod 62(1):132–142
Xing GG, Wang R, Yang B, Zhang D (2006) Postnatal switching of NMDA receptor subunits from NR2B to NR2A in rat facial motor neurons. Eur J Neurosci 24(11):2987–2992. doi:10.1111/j.1460-9568.2006.05188.x
Rinaldi T, Kulangara K, Antoniello K, Markram H (2007) Elevated NMDA receptor levels and enhanced postsynaptic long-term potentiation induced by prenatal exposure to valproic acid. Proc Natl Acad Sci U S A 104(33):13501–13506. doi:10.1073/pnas.0704391104
Lopez-Bendito G, Shigemoto R, Fairen A, Lujan R (2002) Differential distribution of group I metabotropic glutamate receptors during rat cortical development. Cereb Cortex 12(6):625–638
Munoz A, Liu XB, Jones EG (1999) Development of metabotropic glutamate receptors from trigeminal nuclei to barrel cortex in postnatal mouse. J Comp Neurol 409(4):549–566. doi:10.1002/(SICI)1096-9861(19990712)409:4<549::AID-CNE3>3.0.CO;2-I
Nosyreva ED, Huber KM (2005) Developmental switch in synaptic mechanisms of hippocampal metabotropic glutamate receptor-dependent long-term depression. J Neurosci 25(11):2992–3001. doi:10.1523/JNEUROSCI. 3652-04.2005
Walcott EC, Higgins EA, Desai NS (2011) Synaptic and intrinsic balancing during postnatal development in rat pups exposed to valproic acid in utero. J Neurosci 31(37):13097–13109. doi:10.1523/JNEUROSCI. 1341-11.2011
Kumamaru E, Egashira Y, Takenaka R, Takamori S (2014) Valproic acid selectively suppresses the formation of inhibitory synapses in cultured cortical neurons. Neurosci Lett 569:142–147. doi:10.1016/j.neulet.2014.03.066
Moldrich RX, Leanage G, She D, Dolan-Evans E, Nelson M, Reza N, Reutens DC (2013) Inhibition of histone deacetylase in utero causes sociability deficits in postnatal mice. Behav Brain Res 257:253–264. doi:10.1016/j.bbr.2013.09.049
Wang P, Zhang P, Huang J, Li M, Chen X (2013) Trichostatin A protects against cisplatin-induced ototoxicity by regulating expression of genes related to apoptosis and synaptic function. Neurotoxicology 37:51–62. doi:10.1016/j.neuro.2013.03.007
Kramer OH, Zhu P, Ostendorff HP, Golebiewski M, Tiefenbach J, Peters MA, Brill B, Groner B, Bach I, Heinzel T, Gottlicher M (2003) The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2. EMBO J 22(13):3411–3420. doi:10.1093/emboj/cdg315
Chen WY, Weng JH, Huang CC, Chung BC (2007) Histone deacetylase inhibitors reduce steroidogenesis through SCF-mediated ubiquitination and degradation of steroidogenic factor 1 (NR5A1). Mol Cell Biol 27(20):7284–7290. doi:10.1128/MCB. 00476-07
Kong X, Lin Z, Liang D, Fath D, Sang N, Caro J (2006) Histone deacetylase inhibitors induce VHL and ubiquitin-independent proteasomal degradation of hypoxia-inducible factor 1alpha. Mol Cell Biol 26(6):2019–2028. doi:10.1128/MCB. 26.6.2019-2028.2006
Liyanage VR, Zachariah RM, Rastegar M (2013) Decitabine alters the expression of Mecp2 isoforms via dynamic DNA methylation at the Mecp2 regulatory elements in neural stem cells. Mol Autism 4(1):46. doi:10.1186/2040-2392-4-46
Dong E, Guidotti A, Grayson DR, Costa E (2007) Histone hyperacetylation induces demethylation of reelin and 67-kDa glutamic acid decarboxylase promoters. Proc Natl Acad Sci U S A 104(11):4676–4681. doi:10.1073/pnas.0700529104
Milutinovic S, D'Alessio AC, Detich N, Szyf M (2007) Valproate induces widespread epigenetic reprogramming which involves demethylation of specific genes. Carcinogenesis 28(3):560–571. doi:10.1093/carcin/bgl167
Guidotti A, Auta J, Chen Y, Davis JM, Dong E, Gavin DP, Grayson DR, Matrisciano F, Pinna G, Satta R, Sharma RP, Tremolizzo L, Tueting P (2011) Epigenetic GABAergic targets in schizophrenia and bipolar disorder. Neuropharmacology 60(7–8):1007–1016. doi:10.1016/j.neuropharm.2010.10.021
Asai T, Bundo M, Sugawara H, Sunaga F, Ueda J, Tanaka G, Ishigooka J, Kasai K, Kato T, Iwamoto K (2013) Effect of mood stabilizers on DNA methylation in human neuroblastoma cells. Int J Neuropsychopharmacol 16(10):2285–2294. doi:10.1017/S1461145713000710
Selker EU (1998) Trichostatin A causes selective loss of DNA methylation in Neurospora. Proc Natl Acad Sci U S A 95(16):9430–9435
Yang F, Zhang L, Li J, Huang J, Wen R, Ma L, Zhou D, Li L (2010) Trichostatin A and 5-azacytidine both cause an increase in global histone H4 acetylation and a decrease in global DNA and H3K9 methylation during mitosis in maize. BMC Plant Biol 10:178. doi:10.1186/1471-2229-10-178
Palomero-Gallagher N, Bidmon HJ, Zilles K (2003) AMPA, kainate, and NMDA receptor densities in the hippocampus of untreated male rats and females in estrus and diestrus. J Comp Neurol 459(4):468–474. doi:10.1002/cne.10638
Damborsky JC, Winzer-Serhan UH (2012) Effects of sex and chronic neonatal nicotine treatment on Na(2)(+)/K(+)/Cl(-) co-transporter 1, K(+)/Cl(-) co-transporter 2, brain-derived neurotrophic factor, NMDA receptor subunit 2A and NMDA receptor subunit 2B mRNA expression in the postnatal rat hippocampus. Neuroscience 225:105–117. doi:10.1016/j.neuroscience.2012.09.002
Sato D, Lionel AC, Leblond CS, Prasad A, Pinto D, Walker S, O'Connor I, Russell C, Drmic IE, Hamdan FF, Michaud JL, Endris V, Roeth R, Delorme R, Huguet G, Leboyer M, Rastam M, Gillberg C, Lathrop M, Stavropoulos DJ, Anagnostou E, Weksberg R, Fombonne E, Zwaigenbaum L, Fernandez BA, Roberts W, Rappold GA, Marshall CR, Bourgeron T, Szatmari P, Scherer SW (2012) SHANK1 Deletions in males with autism spectrum disorder. Am J Hum Genet 90(5):879–887. doi:10.1016/j.ajhg.2012.03.017
Alonso-Nanclares L, Gonzalez-Soriano J, Rodriguez JR, DeFelipe J (2008) Gender differences in human cortical synaptic density. Proc Natl Acad Sci U S A 105(38):14615–14619. doi:10.1073/pnas.0803652105
Forlano PM, Woolley CS (2010) Quantitative analysis of pre- and postsynaptic sex differences in the nucleus accumbens. J Comp Neurol 518(8):1330–1348. doi:10.1002/cne.22279
Kurian JR, Forbes-Lorman RM, Auger AP (2007) Sex difference in mecp2 expression during a critical period of rat brain development. Epigenetics Off J DNA Methylation Soc 2(3):173–178
Aber KM, Nori P, MacDonald SM, Bibat G, Jarrar MH, Kaufmann WE (2003) Methyl-CpG-binding protein 2 is localized in the postsynaptic compartment: an immunochemical study of subcellular fractions. Neuroscience 116(1):77–80
Maliszewska-Cyna E, Bawa D, Eubanks JH (2010) Diminished prevalence but preserved synaptic distribution of N-methyl-d-aspartate receptor subunits in the methyl CpG binding protein 2(MeCP2)-null mouse brain. Neuroscience 168(3):624–632. doi:10.1016/j.neuroscience.2010.03.065
Nguyen MV, Du F, Felice CA, Shan X, Nigam A, Mandel G, Robinson JK, Ballas N (2012) MeCP2 is critical for maintaining mature neuronal networks and global brain anatomy during late stages of postnatal brain development and in the mature adult brain. J Neurosci 32(29):10021–10034. doi:10.1523/JNEUROSCI. 1316-12.2012
Durand S, Patrizi A, Quast KB, Hachigian L, Pavlyuk R, Saxena A, Carninci P, Hensch TK, Fagiolini M (2012) NMDA receptor regulation prevents regression of visual cortical function in the absence of Mecp2. Neuron 76(6):1078–1090. doi:10.1016/j.neuron.2012.12.004
Blackman MP, Djukic B, Nelson SB, Turrigiano GG (2012) A critical and cell-autonomous role for MeCP2 in synaptic scaling up. J Neurosci 32(39):13529–13536. doi:10.1523/JNEUROSCI. 3077-12.2012
McGraw CM, Samaco RC, Zoghbi HY (2011) Adult neural function requires MeCP2. Science 333(6039):186. doi:10.1126/science.1206593
Chahrour M, Jung SY, Shaw C, Zhou X, Wong ST, Qin J, Zoghbi HY (2008) MeCP2, a key contributor to neurological disease, activates and represses transcription. Science 320(5880):1224–1229. doi:10.1126/science.1153252
Zhang L, He J, Jugloff DG, Eubanks JH (2008) The MeCP2-null mouse hippocampus displays altered basal inhibitory rhythms and is prone to hyperexcitability. Hippocampus 18(3):294–309. doi:10.1002/hipo.20389
Weng SM, McLeod F, Bailey ME, Cobb SR (2011) Synaptic plasticity deficits in an experimental model of rett syndrome: long-term potentiation saturation and its pharmacological reversal. Neuroscience 180:314–321. doi:10.1016/j.neuroscience.2011.01.061
Martin HG, Manzoni OJ (2014) Late onset deficits in synaptic plasticity in the valproic acid rat model of autism. Front Cell Neurosci 8:23. doi:10.3389/fncel.2014.00023
Maezawa I, Jin LW (2010) Rett syndrome microglia damage dendrites and synapses by the elevated release of glutamate. J Neurosci 30(15):5346–5356. doi:10.1523/JNEUROSCI. 5966-09.2010
Acheson A, Conover JC, Fandl JP, DeChiara TM, Russell M, Thadani A, Squinto SP, Yancopoulos GD, Lindsay RM (1995) A BDNF autocrine loop in adult sensory neurons prevents cell death. Nature 374(6521):450–453. doi:10.1038/374450a0
Huang EJ, Reichardt LF (2001) Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci 24:677–736. doi:10.1146/annurev.neuro.24.1.677
Nelson KB, Grether JK, Croen LA, Dambrosia JM, Dickens BF, Jelliffe LL, Hansen RL, Phillips TM (2001) Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation. Ann Neurol 49(5):597–606
Miyazaki K, Narita N, Sakuta R, Miyahara T, Naruse H, Okado N, Narita M (2004) Serum neurotrophin concentrations in autism and mental retardation: a pilot study. Brain Dev 26(5):292–295. doi:10.1016/S0387-7604(03)00168-2
Perry EK, Lee ML, Martin-Ruiz CM, Court JA, Volsen SG, Merrit J, Folly E, Iversen PE, Bauman ML, Perry RH, Wenk GL (2001) Cholinergic activity in autism: abnormalities in the cerebral cortex and basal forebrain. Am J Psychiatr 158(7):1058–1066
Li W, Pozzo-Miller L (2013) BDNF deregulation in Rett syndrome. Neuropharmacology. doi:10.1016/j.neuropharm.2013.03.024
Klein ME, Lioy DT, Ma L, Impey S, Mandel G, Goodman RH (2007) Homeostatic regulation of MeCP2 expression by a CREB-induced microRNA. Nat Neurosci 10(12):1513–1514. doi:10.1038/nn2010
Chang Q, Khare G, Dani V, Nelson S, Jaenisch R (2006) The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression. Neuron 49(3):341–348. doi:10.1016/j.neuron.2005.12.027
Yazdani M, Deogracias R, Guy J, Poot RA, Bird A, Barde YA (2012) Disease modeling using embryonic stem cells: MeCP2 regulates nuclear size and RNA synthesis in neurons. Stem Cells 30(10):2128–2139. doi:10.1002/stem.1180
De Meyer T, Rietzschel ER, De Buyzere ML, De Bacquer D, Van Criekinge W, De Backer GG, Gillebert TC, Van Oostveldt P, Bekaert S, Asklepios I (2007) Paternal age at birth is an important determinant of offspring telomere length. Hum Mol Genet 16(24):3097–3102. doi:10.1093/hmg/ddm271
Chen WG, Chang Q, Lin Y, Meissner A, West AE, Griffith EC, Jaenisch R, Greenberg ME (2003) Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science 302(5646):885–889. doi:10.1126/science.1086446
Martinowich K, Hattori D, Wu H, Fouse S, He F, Hu Y, Fan G, Sun YE (2003) DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science 302(5646):890–893. doi:10.1126/science.1090842
Zhou Z, Hong EJ, Cohen S, Zhao WN, Ho HY, Schmidt L, Chen WG, Lin Y, Savner E, Griffith EC, Hu L, Steen JA, Weitz CJ, Greenberg ME (2006) Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnf transcription, dendritic growth, and spine maturation. Neuron 52(2):255–269. doi:10.1016/j.neuron.2006.09.037
Shahbazian M, Young J, Yuva-Paylor L, Spencer C, Antalffy B, Noebels J, Armstrong D, Paylor R, Zoghbi H (2002) Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3. Neuron 35(2):243–254
De Filippis B, Ricceri L, Fuso A, Laviola G (2013) Neonatal exposure to low dose corticosterone persistently modulates hippocampal mineralocorticoid receptor expression and improves locomotor/exploratory behaviour in a mouse model of Rett syndrome. Neuropharmacology 68:174–183. doi:10.1016/j.neuropharm.2012.05.048
Larimore JL, Chapleau CA, Kudo S, Theibert A, Percy AK, Pozzo-Miller L (2009) Bdnf overexpression in hippocampal neurons prevents dendritic atrophy caused by Rett-associated MECP2 mutations. Neurobiol Dis 34(2):199–211. doi:10.1016/j.nbd.2008.12.011
Acknowledgments
The authors declare no conflict of interests. This work was supported by the Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (no. A120029), and the Framework of International Cooperation Program (2012K2A1A2032549) through the National Research Foundation of Korea (NRF) funded by the Korea government (MEST).
Author information
Authors and Affiliations
Corresponding author
Additional information
Ki Chan Kim and Chang Soon Choi contributed equally to this work
Rights and permissions
About this article
Cite this article
Kim, K.C., Choi, C.S., Kim, JW. et al. MeCP2 Modulates Sex Differences in the Postsynaptic Development of the Valproate Animal Model of Autism. Mol Neurobiol 53, 40–56 (2016). https://doi.org/10.1007/s12035-014-8987-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12035-014-8987-z